Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to confirm the safety (ADR related to beta stimulant drugs, unexpected ADRs) and efficacy of Symbicort in daily practice and the control status on bronchial asthma and Patient satisfaction
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Symbicort | Those with an exposure |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Incidence of Adverse Events | Range of 12 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| The level of asthma control | Range of 12 weeks | |
| The level of patient satisfaction with Symbicort | Range of 12 weeks |
Not provided
Inclusion Criteria:
Exclusion Criteria:
-
Not provided
Not provided
Not provided
Not provided
Patients treated with Symbicort for the first time due to bronchial asthma
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Yoshida Shigeru, MD | AstraZeneca | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Research Site | Okazaki | Aichi-ken | Japan | |||
| Research Site |
Not provided
Not provided
Not provided
Not provided
| Akita |
| Akita |
| Japan |
| Research Site | Aomori | Aomori | Japan |
| Research Site | Chiba | Chiba | Japan |
| Research Site | Ehime | Ehime | Japan |
| Research Site | Fukui-shi | Fukui | Japan |
| Research Site | Fukuoka | Fukuoka | Japan |
| Research Site | Fukushima | Fukushima | Japan |
| Research Site | Gifu | Gifu | Japan |
| Research Site | Gunma | Gunma | Japan |
| Research Site | Hiroshima | Hiroshima | Japan |
| Research Site | Hokkaido | Hokkaido | Japan |
| Research Site | Hyogo | Hyōgo | Japan |
| Research Site | Ibaraki | Ibaraki | Japan |
| Research Site | Ishikawa | Ishikawa-ken | Japan |
| Research Site | Numakunai | Iwate | Japan |
| Research Site | Kagawa | Kagawa-ken | Japan |
| Research Site | Kagoshima | Kagoshima-ken | Japan |
| Research Site | Kanagawa | Kanagawa | Japan |
| Research Site | Kochi | Kochi | Japan |
| Research Site | Kumamoto | Kumamoto | Japan |
| Research Site | Kyoto | Kyoto | Japan |
| Research Site | Miemachi | Mie-ken | Japan |
| Research Site | Miyagi | Miyagi | Japan |
| Research Site | Miyazaki | Miyazaki | Japan |
| Research Site | Nagano | Nagano | Japan |
| Research Site | Nagasaki | Nagasaki | Japan |
| Research Site | Nara | Nara | Japan |
| Research Site | Niigata | Niigata | Japan |
| Research Site | Ōita | Oita Prefecture | Japan |
| Research Site | Okayama | Okayama-ken | Japan |
| Research Site | Okinawa | Okinawa | Japan |
| Research Site | Osaka | Osaka | Japan |
| Research Site | Saga | Saga-ken | Japan |
| Research Site | Saitama | Saitama | Japan |
| Research Site | Shiga | Shiga | Japan |
| Research Site | Shimane | Shimane | Japan |
| Research Site | Shizuoka | Shizuoka | Japan |
| Research Site | Tochigi | Tochigi | Japan |
| Research Site | Tokushima | Tokushima | Japan |
| Research Site | Tokyo | Tokyo | Japan |
| Research Site | Tottori-shi | Tottori | Japan |
| Research Site | Toyama | Toyama | Japan |
| Research Site | Wakayama | Wakayama | Japan |
| Research Site | Yamagata | Yamagata | Japan |
| Research Site | Yamaguchi | Yamaguchi | Japan |
| Research Site | Yamanashi | Yamanashi | Japan |
| ID | Term |
|---|---|
| D001249 | Asthma |
| ID | Term |
|---|---|
| D001982 | Bronchial Diseases |
| D012140 | Respiratory Tract Diseases |
| D008173 | Lung Diseases, Obstructive |
| D008171 | Lung Diseases |
| D012130 | Respiratory Hypersensitivity |
| D006969 | Hypersensitivity, Immediate |
| D006967 | Hypersensitivity |
| D007154 | Immune System Diseases |
Not provided
Not provided